Fabrice Lacan

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

CYP 17 and CYP 19 Inhibitors. Evaluation of Fluorine Effects on the Inhibiting Activity of Regioselectively Fluorinated 1-(Naphthalen-2-ylmethyl)imidazoles

Rolf W. Hartmann, Anja Palusczak, Fabrice Lacan et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2004 · 19 citations

Natural Sciences, Chemistry, Pharmacology +11

Thromboxane A2 Receptor Antagonism in Man and Rat by a Sulphonylcyanoguanidine (BM-144) and a Sulphonylurea (BM-500)

Bernard Masereel, J. Damas, Jeanine Fontaine et al. · Journal of Pharmacy and Pharmacology · 1999 · 16 citations · Full text

Medicine, Cardiology, Pharmacology +11

Use of Infrared Spectroscopy in Monitoring a New Method for the Preparation of Sulotroban, an Antithrombotic Drug: A Medicinal Chemistry Experiment

Alain Nührich, Martine Varache‐Lembège, Fabrice Lacan et al. · Journal of Chemical Education · 1996 · 10 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Study of the ring closure reaction of o-aminoarylsulfonamides with 1,1′-thiocarbonyldiimidazole.

Pascal De Tullio, Bernard Pirotte, F. Somers et al. · Tetrahedron · 1998 · 10 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7